Purchase Order 75N94022P00280
Award Date
4/30/22
Potential Completion Date
4/29/27
Potential Value
$201K
Funding Federal Agency
National Institute of Diabetes and Digestive and Kidney Diseases
Contracting Federal Agency
National Institute of Child Health and Human Development
Awardee
Illumina, Inc.
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services, National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a firm-fixed-price purchase order to Illumina, Inc., a manufacturer of genomic sequencing instruments and reagents, for the procurement of a NextSeq 550 Sequencing System. The contract, valued at $266,475.00, was awarded on August 15, 2019, with a completion date of November 18, 2019. The NextSeq 550 system will be used by the NIDDK...
The Department of Health and Human Services, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases awarded a firm fixed price delivery order contract to Illumina, Inc., a for-profit manufacturer of genomic sequencing and analysis instruments and reagents. The $145,808.65 award is for the provision of Illumina's proprietary NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, along with associated consumables and support services. This award is not...
This is a $5,216.64 firm fixed price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency under the National Institutes of Health (NIH), to Illumina, Inc. for the provision of sequencing systems, reagents, and related services. The award has no set-aside designation. Illumina, a for-profit manufacturer, has previously supported genomic sequencing and analysis efforts across various federal agencies including the NIH, CDC, USDA,...
The Department of Health and Human Services National Institutes of Health Office of Logistics and Acquisition Operations awarded a firm fixed-price purchase order to Illumina, Inc., a manufacturer of genetic and genomic analysis instruments and reagents, to provide a NextSeq 550 sequencing system and associated support plan. The total potential value of the contract is $392,924.00, with a completion date of September 29, 2025. The contract was awarded on a sole-source basis, with no set-aside...
The Department of Health and Human Services National Institutes of Health (NIH) awarded a firm fixed price purchase order to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and reagents, for the supply of an Illumina NextSeq2000 DNA sequencer. The $239,700 contract is intended to support the sequencing and genomic analysis work of the NIH's National Institute on Deafness and Other Communication Disorders (NIDCD) Genomics and Computational Biology Core. The award was...
The Department of Health and Human Services' National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a firm fixed-price delivery order contract to Illumina, Inc., a for-profit manufacturer of sequencing and genomics analysis equipment. The $193,926.00 contract, which has a completion date of September 2, 2025, is for the provision of consumables to support NIDDK's research and diagnostic activities. Illumina has a history of federal contract...
This is a firm fixed-price purchase order contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency within the Department of Health and Human Services (HHS), to Illumina, Inc. The contract, valued at $72,422.58, is for the provision of Illumina's sequencing instruments, reagents, and related products and services to support NIDDK's genomic research and analysis needs. Illumina has previously served as a prime contractor and...
This firm fixed-price delivery order contract was awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $76,500.00 contract provides Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, along with associated reagents, consumables, sample prep kits, sequencing chips, support plans, maintenance services, and bioinformatics...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price purchase order to Illumina, Inc., a for-profit manufacturer, for a NextSeq 550 Sequencing System and associated support services. The potential value of the contract is $316,250.00. There was no set-aside used for this award. The contract was issued under the statutory authority of 41 U.S.C. 253 (c) (1), citing only one source available for...
This federal contract award was issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, to Illumina, Inc., a for-profit manufacturer of genomic sequencing and analysis instruments and reagents. The $99,745.80 firm fixed price delivery order contract is for the provision of various NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, along with supporting reagents, consumables, and services. The contract does not have a set-aside designation....